Recovery from Hepatitis C virus (HCV) infection is considered infrequent (p = 0.0053). The dominance of genotype 2 HCV strains and high frequency of HLAA-B*57 may be important factors explaining the high rate of recovery from HCV infection in Ghana. The second objective of this project was to assess the antigenicity of the recombinant genotype 2 F protein in donors with either chronic infection or recovery identified previously. Purified F and core proteins were used to develop immunoassays to detect anti-F and anti-core in titrated plasma samples. The level of HCV antibodies was also titrated using a commercial anti-HCV kit. The results showed that the reactivity of F protein was significantly higher (p <0.001) in donors with chronic infec...
We tested serum samples from blood donors by using first-, second-, and third-generation enzyme immu...
The hepatitis C virus (HCV) was the first described human pathogen of the hepaciviruses,a new genus ...
Hepatitis C virus (HCV) infection is a major global health problem. In the majority of cases the vir...
To date, all studies regarding hepatitis C virus (HCV) F protein have been based on expression in vi...
Recovery from Hepatitis C virus (HCV) infection is considered infrequent (<20%) in western populatio...
The relationship between hepatitis C virus (HCV) genotypes and antibody status was studied in 104 ch...
Hepatitis C virus (HCV) causes acute and chronic liver diseases in humans. Its two envelope glycopro...
An enzyme immunoassay (EIA) which utilizes a solid phase coated with a recombinant antigen (c100-3) ...
Recently a recombinant polypeptide of hepatitis C virus (HCV) has been developed by the Chiron Corpo...
Worldwide, approximately 170 million people are infected with the hepatitis C virus (HCV), which giv...
To study the virological and serological characteristics of asymptomatic hepatitis C virus (HCV) car...
Hepatitis C is one of the leading causes of hepatocellular carcinoma and remains at a high prevalenc...
This study was undertaken to evaluate an enzyme immunoassay (EIA) for hepatitis C virus antibody det...
Recently, two distinct hepatitis C virus (HCV) serologic types have been identified on the basis of ...
Crude extract from Escherichia coli which expressed a recombinant protein containing amino acids 2 t...
We tested serum samples from blood donors by using first-, second-, and third-generation enzyme immu...
The hepatitis C virus (HCV) was the first described human pathogen of the hepaciviruses,a new genus ...
Hepatitis C virus (HCV) infection is a major global health problem. In the majority of cases the vir...
To date, all studies regarding hepatitis C virus (HCV) F protein have been based on expression in vi...
Recovery from Hepatitis C virus (HCV) infection is considered infrequent (<20%) in western populatio...
The relationship between hepatitis C virus (HCV) genotypes and antibody status was studied in 104 ch...
Hepatitis C virus (HCV) causes acute and chronic liver diseases in humans. Its two envelope glycopro...
An enzyme immunoassay (EIA) which utilizes a solid phase coated with a recombinant antigen (c100-3) ...
Recently a recombinant polypeptide of hepatitis C virus (HCV) has been developed by the Chiron Corpo...
Worldwide, approximately 170 million people are infected with the hepatitis C virus (HCV), which giv...
To study the virological and serological characteristics of asymptomatic hepatitis C virus (HCV) car...
Hepatitis C is one of the leading causes of hepatocellular carcinoma and remains at a high prevalenc...
This study was undertaken to evaluate an enzyme immunoassay (EIA) for hepatitis C virus antibody det...
Recently, two distinct hepatitis C virus (HCV) serologic types have been identified on the basis of ...
Crude extract from Escherichia coli which expressed a recombinant protein containing amino acids 2 t...
We tested serum samples from blood donors by using first-, second-, and third-generation enzyme immu...
The hepatitis C virus (HCV) was the first described human pathogen of the hepaciviruses,a new genus ...
Hepatitis C virus (HCV) infection is a major global health problem. In the majority of cases the vir...